Pub Date : 2025-01-01Epub Date: 2025-09-04DOI: 10.1159/000547567
William W N Tsang, Yuen Ting Wong, Joshua S H Tsang
Introduction: The aim of this study was to investigate the effects of 3 months of seated Tai Chi (TC) practice on the eye-hand coordination and sitting balance control of subjects with Parkinson's disease.
Method: A prospective non-randomized study was conducted with 29 subjects practicing TC and 27 subjects as controls according to their preference. The seated TC group underwent 3 months of training with a total of 24 sessions (1 h/session, 2 sessions/week). The outcome measures included a dynamic finger-pointing task (reaction time, movement time, and accuracy), and a sequential weight-shifting balance control test (completion time) while seated.
Results: The TC group showed faster movement time in the dynamic finger-pointing task (p = 0.003). They also achieved a faster completion time of the sequential weight-shifting balance test (p = 0.021). No significant difference was observed in the control group.
Conclusions: The results demonstrate that 3 months of seated TC training could improve movement time in the finger-pointing task and sitting balance control in subjects with Parkinson's disease. A future randomized controlled trial is warranted.
{"title":"Seated Tai Chi Improves Dynamic Finger-Pointing Task and Sitting Balance Control in Subjects with Parkinson's Disease: A Prospective Comparative Observational Study.","authors":"William W N Tsang, Yuen Ting Wong, Joshua S H Tsang","doi":"10.1159/000547567","DOIUrl":"10.1159/000547567","url":null,"abstract":"<p><strong>Introduction: </strong>The aim of this study was to investigate the effects of 3 months of seated Tai Chi (TC) practice on the eye-hand coordination and sitting balance control of subjects with Parkinson's disease.</p><p><strong>Method: </strong>A prospective non-randomized study was conducted with 29 subjects practicing TC and 27 subjects as controls according to their preference. The seated TC group underwent 3 months of training with a total of 24 sessions (1 h/session, 2 sessions/week). The outcome measures included a dynamic finger-pointing task (reaction time, movement time, and accuracy), and a sequential weight-shifting balance control test (completion time) while seated.</p><p><strong>Results: </strong>The TC group showed faster movement time in the dynamic finger-pointing task (p = 0.003). They also achieved a faster completion time of the sequential weight-shifting balance test (p = 0.021). No significant difference was observed in the control group.</p><p><strong>Conclusions: </strong>The results demonstrate that 3 months of seated TC training could improve movement time in the finger-pointing task and sitting balance control in subjects with Parkinson's disease. A future randomized controlled trial is warranted.</p>","PeriodicalId":10541,"journal":{"name":"Complementary Medicine Research","volume":" ","pages":"273-282"},"PeriodicalIF":0.8,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144999833","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-01-01Epub Date: 2025-07-02DOI: 10.1159/000547181
Jozélio Freire de Carvalho, Aaron Lerner, Carina Benzvi
Background: Garlic and garlic extract (GE) are highly consumed traditional and popular food spices. They are reported to have antioxidant, anti-inflammatory, and infection-protecting properties. The aim of this study was to review the use of GE in various rheumatic diseases.
Summary: PubMed/MEDLINE, Embase, and SciELO were searched for articles on GE and rheumatic diseases between 1966 and May 2024. Four articles were found, including 176 patients. The investigated diseases were rheumatoid arthritis (RA) (n = 3) and osteoarthritis (OA) (n = 1). Age varied from 51.06 ± 13.8 to 58.9 ± 7.5 years old, and female gender was the only one included in all studies. The disease duration was 6.58 ± 7.75 years. The GE dosage ranged from 600 mg to 1,000 mg/day. The follow-up ranged from 4 to 12 weeks. All articles demonstrated improvements in the diverse rheumatic disease parameters (e.g., pain, function, disease activity, tender and swollen joints, stiffness, and WOMAC) and reduced inflammatory biomarkers (C-reactive protein, tumor necrosis factor, malondialdehyde).
Key messages: GE is a safe and well-tolerated therapy for RA and OA. However, studies with more participants are needed to confirm, replicate, and further explore the topic.
{"title":"Garlic Extract in Rheumatological Diseases: A Systematic Review.","authors":"Jozélio Freire de Carvalho, Aaron Lerner, Carina Benzvi","doi":"10.1159/000547181","DOIUrl":"10.1159/000547181","url":null,"abstract":"<p><strong>Background: </strong>Garlic and garlic extract (GE) are highly consumed traditional and popular food spices. They are reported to have antioxidant, anti-inflammatory, and infection-protecting properties. The aim of this study was to review the use of GE in various rheumatic diseases.</p><p><strong>Summary: </strong>PubMed/MEDLINE, Embase, and SciELO were searched for articles on GE and rheumatic diseases between 1966 and May 2024. Four articles were found, including 176 patients. The investigated diseases were rheumatoid arthritis (RA) (n = 3) and osteoarthritis (OA) (n = 1). Age varied from 51.06 ± 13.8 to 58.9 ± 7.5 years old, and female gender was the only one included in all studies. The disease duration was 6.58 ± 7.75 years. The GE dosage ranged from 600 mg to 1,000 mg/day. The follow-up ranged from 4 to 12 weeks. All articles demonstrated improvements in the diverse rheumatic disease parameters (e.g., pain, function, disease activity, tender and swollen joints, stiffness, and WOMAC) and reduced inflammatory biomarkers (C-reactive protein, tumor necrosis factor, malondialdehyde).</p><p><strong>Key messages: </strong>GE is a safe and well-tolerated therapy for RA and OA. However, studies with more participants are needed to confirm, replicate, and further explore the topic.</p>","PeriodicalId":10541,"journal":{"name":"Complementary Medicine Research","volume":" ","pages":"296-300"},"PeriodicalIF":0.8,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144552517","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-01-01Epub Date: 2025-09-01DOI: 10.1159/000547403
Silin Ou, Ming Dong, Ying Wei, Hongmei Huan, Wenqian Wang
Background: With a wide range of clinical needs, evidence-based support for acupuncture therapy through clinical trials is essential for enhancing its scientific value, clinical application, and international influence.
Objective: The aim of this study was to provide design ideas and specific methodology references for acupuncturists and researchers for the design, implementation, and publication of high-level acupuncture clinical research.
Data sources: The data came from PubMed, Web of Science, and EBSCO databases since its inception until February 28, 2024. A total of 89 articles were retrieved, and the primary interventions were manual acupuncture, electroacupuncture, auricular acupuncture, and laser acupuncture. Eighty-five clinical trials on manual acupuncture and electroacupuncture as primary interventions were included.
Results: All of the high-quality clinical trial publications on acupuncture included in the review adhered to the Consolidated Standards of Reporting Trials (CONSORT) statement and the Standards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA). They demonstrated rigor and accuracy in trial design selection, inclusion criteria development, sample size calculations, and statistical methodology, and provided clear, concise details of acupuncture interventions and control settings.
Conclusion: These trials have elevated the overall quality of the research and provided invaluable insights and methodological frameworks for designing randomized controlled trials (RCTs) in acupuncture. Despite these advancements, several limitations remain that warrant attention in future endeavors. Addressing these shortcomings is crucial for enhancing the methodological rigor and reliability of acupuncture trials and advancing evidence-based practice in this field.
背景:针灸治疗具有广泛的临床需求,通过临床试验为针灸疗法提供循证支持是提高其科学价值、临床应用和国际影响力的必要条件。目的:为针灸师和科研人员设计、实施和发表高水平针灸临床研究提供设计思路和具体方法论参考。数据来源:数据来自Pubmed, Web of Science和EBSCO数据库,从成立到2024年2月28日。共检索到91篇文献,主要干预措施为手针、电针、耳针和激光针。纳入85项以手针和电针为主要干预措施的临床试验。结果:纳入本综述的所有高质量的针灸临床试验出版物均遵守试验综合报告标准(CONSORT)声明和针灸临床试验干预措施报告标准(STRICTA)。他们在试验设计选择、纳入标准制定、样本量计算、统计方法方面表现出严谨性和准确性,并提供了针灸干预和对照设置的清晰、简明的细节。结论:这些试验提高了研究的整体质量,并为设计针灸随机对照试验(rct)提供了宝贵的见解和方法框架。尽管取得了这些进步,但仍存在一些限制,值得在未来的努力中加以注意。解决这些缺点对于提高针灸试验方法的严谨性和可靠性以及推进该领域的循证实践至关重要。
{"title":"Commonality Analysis of High-Quality Acupuncture Clinical Trial Articles.","authors":"Silin Ou, Ming Dong, Ying Wei, Hongmei Huan, Wenqian Wang","doi":"10.1159/000547403","DOIUrl":"10.1159/000547403","url":null,"abstract":"<p><strong>Background: </strong>With a wide range of clinical needs, evidence-based support for acupuncture therapy through clinical trials is essential for enhancing its scientific value, clinical application, and international influence.</p><p><strong>Objective: </strong>The aim of this study was to provide design ideas and specific methodology references for acupuncturists and researchers for the design, implementation, and publication of high-level acupuncture clinical research.</p><p><strong>Data sources: </strong>The data came from PubMed, Web of Science, and EBSCO databases since its inception until February 28, 2024. A total of 89 articles were retrieved, and the primary interventions were manual acupuncture, electroacupuncture, auricular acupuncture, and laser acupuncture. Eighty-five clinical trials on manual acupuncture and electroacupuncture as primary interventions were included.</p><p><strong>Results: </strong>All of the high-quality clinical trial publications on acupuncture included in the review adhered to the Consolidated Standards of Reporting Trials (CONSORT) statement and the Standards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA). They demonstrated rigor and accuracy in trial design selection, inclusion criteria development, sample size calculations, and statistical methodology, and provided clear, concise details of acupuncture interventions and control settings.</p><p><strong>Conclusion: </strong>These trials have elevated the overall quality of the research and provided invaluable insights and methodological frameworks for designing randomized controlled trials (RCTs) in acupuncture. Despite these advancements, several limitations remain that warrant attention in future endeavors. Addressing these shortcomings is crucial for enhancing the methodological rigor and reliability of acupuncture trials and advancing evidence-based practice in this field.</p>","PeriodicalId":10541,"journal":{"name":"Complementary Medicine Research","volume":" ","pages":"314-325"},"PeriodicalIF":0.8,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144945755","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-01-01Epub Date: 2025-10-14DOI: 10.1159/000548880
Hiroshi Kondo, Erika Matsuda, Shingo Ogawa, Hiroshi Nishimura, Akira Ono
Background: Home healthcare massage is widely used in Japan under insurance coverage, yet scientific evidence on its effectiveness and adverse events remains limited.
Objective: The aims of the study were to examine effectiveness and predictors of improvement in disabled older adults receiving home healthcare massage and to describe adverse events.
Methods: A retrospective cohort study included 469 participants (mean age 80.2 years; 65.7% women) from 10 clinics. Outcomes at baseline and 1 year were the level of nursing care required, the degree of independent living, and 15 basic activities of daily living. Participants were classified as improved, unchanged, or worsened. Logistic regression identified predictors of improvement. Adverse events during 1 year were recorded.
Results: Improvement was associated with a mild level of nursing care required at baseline (OR = 0.865), muscle atrophy (OR = 1.87), and no use of services other than massage (OR = 0.439). Maintenance without deterioration was also considered clinically meaningful. Ninety-six adverse events (20.5%) were reported, most frequently pain, followed by abrasions/contusions/bruises and numbness. Severity, causality, and temporal course were not collected.
Conclusion: Home healthcare massage may contribute to functional improvement under specific conditions, though most participants received combination therapies. These findings reflect real-world practice in Japan and support the need for large-scale prospective studies.
{"title":"Home Healthcare Massage for Disabled Older Adults in Japan: Factors Associated with Improvement and Adverse Events.","authors":"Hiroshi Kondo, Erika Matsuda, Shingo Ogawa, Hiroshi Nishimura, Akira Ono","doi":"10.1159/000548880","DOIUrl":"10.1159/000548880","url":null,"abstract":"<p><strong>Background: </strong>Home healthcare massage is widely used in Japan under insurance coverage, yet scientific evidence on its effectiveness and adverse events remains limited.</p><p><strong>Objective: </strong>The aims of the study were to examine effectiveness and predictors of improvement in disabled older adults receiving home healthcare massage and to describe adverse events.</p><p><strong>Methods: </strong>A retrospective cohort study included 469 participants (mean age 80.2 years; 65.7% women) from 10 clinics. Outcomes at baseline and 1 year were the level of nursing care required, the degree of independent living, and 15 basic activities of daily living. Participants were classified as improved, unchanged, or worsened. Logistic regression identified predictors of improvement. Adverse events during 1 year were recorded.</p><p><strong>Results: </strong>Improvement was associated with a mild level of nursing care required at baseline (OR = 0.865), muscle atrophy (OR = 1.87), and no use of services other than massage (OR = 0.439). Maintenance without deterioration was also considered clinically meaningful. Ninety-six adverse events (20.5%) were reported, most frequently pain, followed by abrasions/contusions/bruises and numbness. Severity, causality, and temporal course were not collected.</p><p><strong>Conclusion: </strong>Home healthcare massage may contribute to functional improvement under specific conditions, though most participants received combination therapies. These findings reflect real-world practice in Japan and support the need for large-scale prospective studies.</p>","PeriodicalId":10541,"journal":{"name":"Complementary Medicine Research","volume":" ","pages":"463-473"},"PeriodicalIF":0.8,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145291388","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Trigeminal herpetic neuralgia, a common type of Zoster-associated pain (ZAP), affects individuals across all ages groups and poses a significant societal burden all over the world. Electroacupuncture (EA) is increasingly used in the treatment of ZAP due to its affordability, high safety profile, absence of adverse reactions, and high patient acceptance. Consequently, it is essential to conduct randomized controlled trials to evaluate the effectiveness and safety of EA in treating ZAP and to determine if EA can be used as an alternative to pregabalin.
Patients and methods: A total of 102 patients with trigeminal herpetic neuralgia will be enrolled from 2 hospitals and randomly assigned to the EA group, pregabalin group, or EA + pregabalin group in a 1:1:1 ratio using a simple random number table. The study will consist of a 4-week treatment period followed by a 4-week follow-up period. The primary outcome measure will be pain intensity, while secondary outcomes will include mood state, sleep quality, and quality of life. Adverse reactions will be thoroughly evaluated.
Conclusion: This study aims to elucidate the clinical effectiveness of EA combined with pregabalin for trigeminal herpetic neuralgia and to objectively compare the effectiveness and safety of EA versus oral pregabalin in the treatment of trigeminal herpetic neuralgia.
{"title":"Effectiveness of Electroacupuncture Combined with Pregabalin in the Treatment of Trigeminal Herpetic Neuralgia: A Multicenter Randomized Controlled Trial Study Protocol.","authors":"Shimin Li, Xilong Yang, Yunfan Xia, Yunyan Shen, Jingfang Li, Chengcheng Kong, Hui Wang, Ruohan Sun, Zhiyuan Bian, Zuyong Zhang, Jianqiao Fang, Ping Lin","doi":"10.1159/000549320","DOIUrl":"10.1159/000549320","url":null,"abstract":"<p><strong>Background: </strong>Trigeminal herpetic neuralgia, a common type of Zoster-associated pain (ZAP), affects individuals across all ages groups and poses a significant societal burden all over the world. Electroacupuncture (EA) is increasingly used in the treatment of ZAP due to its affordability, high safety profile, absence of adverse reactions, and high patient acceptance. Consequently, it is essential to conduct randomized controlled trials to evaluate the effectiveness and safety of EA in treating ZAP and to determine if EA can be used as an alternative to pregabalin.</p><p><strong>Patients and methods: </strong>A total of 102 patients with trigeminal herpetic neuralgia will be enrolled from 2 hospitals and randomly assigned to the EA group, pregabalin group, or EA + pregabalin group in a 1:1:1 ratio using a simple random number table. The study will consist of a 4-week treatment period followed by a 4-week follow-up period. The primary outcome measure will be pain intensity, while secondary outcomes will include mood state, sleep quality, and quality of life. Adverse reactions will be thoroughly evaluated.</p><p><strong>Conclusion: </strong>This study aims to elucidate the clinical effectiveness of EA combined with pregabalin for trigeminal herpetic neuralgia and to objectively compare the effectiveness and safety of EA versus oral pregabalin in the treatment of trigeminal herpetic neuralgia.</p>","PeriodicalId":10541,"journal":{"name":"Complementary Medicine Research","volume":" ","pages":"485-494"},"PeriodicalIF":0.8,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145421461","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Objective: The objective of this study was to examine the efficacy and safety of pestle needle therapy (PNT) across several prevalent conditions, including insomnia, cervical spondylosis, lumbar disc herniation, and other systemic diseases.
Methods: We searched eight databases (SINOMED, China National Knowledge Infrastructure, Wanfang Data, VIP Database, Google Scholar, PubMed, Embase, and Web of Science) from inception to 31 December 2023, using both subject terms and free-text terms related to "pestle needle" and "randomised controlled trial." Eligible randomised controlled trials (RCTs) that investigated PNT alone or in combination with other therapies were included. Primary outcomes included the overall response rate (ORR) and incidence of adverse events.
Results: A total of 29 RCTs involving 2,614 patients were included. Meta-analysis results showed that, compared with controls, PNT significantly improved ORR in insomnia (odds ratio [OR] = 4.07, 95% confidence interval [CI]: 2.33, 7.09), cervical spondylosis (OR = 4.38, 95% CI: 2.41, 7.97), lumbago and leg pain (OR = 3.32, 95% CI: 1.86, 5.91), and lumbar disc herniation (OR = 1.92, 95% CI: 1.12, 3.29). Regarding cervical spondylosis, the intervention of the observation group was significantly better than that of the control group (Z = 4.84, p < 0.001). In terms of low back pain and leg pain, the intervention of the observation group was significantly better than that of the control group (Z = 4.07, p < 0.001). The intervention of the observation group was significantly better than in the control group in improving the total effective rate of the treatment of lumbar disc herniation (Z = 2.37, p = 0.02).
Conclusion: PNT is a safe and effective treatment modality that can complement or substitute conventional interventions. This systematic review and meta-analysis contributes to the evidence base for acupuncture-related therapies, highlighting the potential of PNT to address both musculoskeletal and neurological conditions, thus offering new clinical options and underscoring the need for large-scale, high-quality RCTs to refine treatment protocols.
{"title":"Systematic Review and Meta-Analysis of Pestle Needle Therapy in Managing Insomnia, Cervical Spondylosis, and Other Systemic Diseases.","authors":"Jiaqi Wang, Yingchao Wang, Shudan Yu, Shujun Li, Ning Liu, Genghui Zhang","doi":"10.1159/000546785","DOIUrl":"10.1159/000546785","url":null,"abstract":"<p><strong>Objective: </strong>The objective of this study was to examine the efficacy and safety of pestle needle therapy (PNT) across several prevalent conditions, including insomnia, cervical spondylosis, lumbar disc herniation, and other systemic diseases.</p><p><strong>Methods: </strong>We searched eight databases (SINOMED, China National Knowledge Infrastructure, Wanfang Data, VIP Database, Google Scholar, PubMed, Embase, and Web of Science) from inception to 31 December 2023, using both subject terms and free-text terms related to \"pestle needle\" and \"randomised controlled trial.\" Eligible randomised controlled trials (RCTs) that investigated PNT alone or in combination with other therapies were included. Primary outcomes included the overall response rate (ORR) and incidence of adverse events.</p><p><strong>Results: </strong>A total of 29 RCTs involving 2,614 patients were included. Meta-analysis results showed that, compared with controls, PNT significantly improved ORR in insomnia (odds ratio [OR] = 4.07, 95% confidence interval [CI]: 2.33, 7.09), cervical spondylosis (OR = 4.38, 95% CI: 2.41, 7.97), lumbago and leg pain (OR = 3.32, 95% CI: 1.86, 5.91), and lumbar disc herniation (OR = 1.92, 95% CI: 1.12, 3.29). Regarding cervical spondylosis, the intervention of the observation group was significantly better than that of the control group (Z = 4.84, p < 0.001). In terms of low back pain and leg pain, the intervention of the observation group was significantly better than that of the control group (Z = 4.07, p < 0.001). The intervention of the observation group was significantly better than in the control group in improving the total effective rate of the treatment of lumbar disc herniation (Z = 2.37, p = 0.02).</p><p><strong>Conclusion: </strong>PNT is a safe and effective treatment modality that can complement or substitute conventional interventions. This systematic review and meta-analysis contributes to the evidence base for acupuncture-related therapies, highlighting the potential of PNT to address both musculoskeletal and neurological conditions, thus offering new clinical options and underscoring the need for large-scale, high-quality RCTs to refine treatment protocols.</p>","PeriodicalId":10541,"journal":{"name":"Complementary Medicine Research","volume":" ","pages":"341-353"},"PeriodicalIF":0.8,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144301277","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Introduction - Hypopharyngeal squamous cell carcinoma has poor prognosis with only 25% chances of 5 years of relative survival in such patients in spite of conventional treatment including radical surgery, radiotherapy and concurrent chemotherapy. Case Presentation - A chronic tobacco - betel nut chewer 62-years-old male patient had dysphagia with hoarseness of voice diagnosed with stage III, grade II malignant pyriform fossa. The patient underwent 9 cycles of neo adjuvant chemotherapy with Inj Paclitaxel 100 mg and Inj Cisplatin 40 mg. He was then referred to our institute for Radical Radiotherapy with Concurrent Chemotherapy with adjunct Ayurvedic treatment. A total dose of 70 Gy of radiation with cobalt 60 source was administered to the bilateral face and neck, in 35 fractions. Patient also received 6 cycles of concurrent weekly chemotherapy with Inj Cisplatin 40 mg. He received well planned adjunct Ayurvedic treatment in the form of Oral Ayurvedic Medicines (OAM) and Detoxifying treatment, Panchakarma. All the measured adverse effects of radiotherapy such as Stomatitis, Xerostomia, Taste Alteration, Dysphagia, Nausea etc. were observed to be remarkably low during and post radiotherapy in this patient. Karnofsky and QoL scores revealed patient's wellbeing throughout the treatment course. After 5 years PET CT scan revealed no FDG avid loco regional recurrence or distant organ involvement implying Disease Free Survival (DFS). Various Chemokines, cytokines and oxidative stress were assessed during the course of treatment to observe tumour microenvironment. Conclusion - Present case of HNC, Stage III and Grade II belonged to high-grade, high-risk hypopharyngeal cancer with poor prognosis. The patient opted for Ayurvedic treatment besides radiotherapy which continued thereafter for 5 years. We therefore emphasize that in this case, minimum side effects of radiotherapy, immunomodulation and reduction in inflammation and oxidative stress along with good quality of life can be attributed to OAM and repeated detoxifying Panchakarma treatment supported with healthy diet and good lifestyle. The highlight of the study is the marked effect on the patient's immune response and reduction in oxidative stress leading to 5 years and beyond of DFS.
{"title":"Selective adjuvant Ayurvedic treatment modulates immune response and oxidative stress in patient with carcinoma of pyriform fossa, undergoing radiotherapy: A case study.","authors":"Vineeta Deshmukh,Shubhada Chiplunkar,Sadanand Sardeshmukh,Tushar Patil,Jagdish Shinde,Vidya Gupta,Shweta Gujar,Nilambari Sardeshmukh,Shridevi Pathak,Sandeep Chavan,Trupti Pradhan,Jueelee Godbole","doi":"10.1159/000541254","DOIUrl":"https://doi.org/10.1159/000541254","url":null,"abstract":"Introduction - Hypopharyngeal squamous cell carcinoma has poor prognosis with only 25% chances of 5 years of relative survival in such patients in spite of conventional treatment including radical surgery, radiotherapy and concurrent chemotherapy. Case Presentation - A chronic tobacco - betel nut chewer 62-years-old male patient had dysphagia with hoarseness of voice diagnosed with stage III, grade II malignant pyriform fossa. The patient underwent 9 cycles of neo adjuvant chemotherapy with Inj Paclitaxel 100 mg and Inj Cisplatin 40 mg. He was then referred to our institute for Radical Radiotherapy with Concurrent Chemotherapy with adjunct Ayurvedic treatment. A total dose of 70 Gy of radiation with cobalt 60 source was administered to the bilateral face and neck, in 35 fractions. Patient also received 6 cycles of concurrent weekly chemotherapy with Inj Cisplatin 40 mg. He received well planned adjunct Ayurvedic treatment in the form of Oral Ayurvedic Medicines (OAM) and Detoxifying treatment, Panchakarma. All the measured adverse effects of radiotherapy such as Stomatitis, Xerostomia, Taste Alteration, Dysphagia, Nausea etc. were observed to be remarkably low during and post radiotherapy in this patient. Karnofsky and QoL scores revealed patient's wellbeing throughout the treatment course. After 5 years PET CT scan revealed no FDG avid loco regional recurrence or distant organ involvement implying Disease Free Survival (DFS). Various Chemokines, cytokines and oxidative stress were assessed during the course of treatment to observe tumour microenvironment. Conclusion - Present case of HNC, Stage III and Grade II belonged to high-grade, high-risk hypopharyngeal cancer with poor prognosis. The patient opted for Ayurvedic treatment besides radiotherapy which continued thereafter for 5 years. We therefore emphasize that in this case, minimum side effects of radiotherapy, immunomodulation and reduction in inflammation and oxidative stress along with good quality of life can be attributed to OAM and repeated detoxifying Panchakarma treatment supported with healthy diet and good lifestyle. The highlight of the study is the marked effect on the patient's immune response and reduction in oxidative stress leading to 5 years and beyond of DFS.","PeriodicalId":10541,"journal":{"name":"Complementary Medicine Research","volume":"196 1","pages":"1-23"},"PeriodicalIF":1.8,"publicationDate":"2024-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142247394","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
INTRODUCTIONThis systematic review examines the efficacy of a combination of Qi benefiting and blood circulation promoting herbs with Dapagliflozin in treating type 2 diabetes mellitus (T2DM) combined with heart failure (HF).METHODSRandomized controlled trials (RCTs) assessing the combination of Qi benefiting and blood circulation promoting herbs with Dapagliflozin for T2DM and CHF was conducted. The search, spanning from the database's establishment to June 2023, included seven databases: China Knowledge Network (CNKI), Wanfang Database, VIP Database, PubMed, Embase, Cochrane Library, and the Chinese Biomedical Literature Database. Two researchers screened and extracted data based on inclusion and exclusion criteria. The Cochrane Handbook version 5.1 guided the quality assessment of studies, and the meta-analysis was performed using RevMan 5.4 software.RESULTSEleven articles, encompassing a sample size of 1192 cases, were included. Meta-analysis results indicated that combining Qi benefiting and blood circulation promoting herbs with Dapagliflozin improved the clinical efficacy rate [OR=4.35, 95% CI (2.98, 6.35), P<0.00001]. It reduced blood glucose levels, evidenced by decreased fasting blood glucose (FBG) [MD=-1.19, 95% CI (-1.30, -1.09), P<0.00001], 2-hour postprandial blood glucose (2hPG) [MD=-1.95, 95% CI (-2.09, -1.80), P<0.00001], and glycosylated haemoglobin (HbA1c) [MD=-1.40, 95% CI (-1.49, -1.31), P<0.00001]. Inflammatory factors also reduced, including C-reactive protein (CRP) [MD=-4.93, 95% CI (-5.38, -4.48), P<0.00001], tumor necrosis factor (TNF-α) [MD=-2.91, 95% CI (-3.32, -2.49), P<0.00001], and interleukin-6 (IL-6) [MD=-11.10, 95% CI (-12.43, -9.43), P<0.00001]. Additionally, left ventricular end-diastolic diameter (LVEDD) [SMD=-1.25, 95% CI (-1.45, -1.05), P<0.00001], left ventricular end-systolic diameter (LVESD) [SMD=-1.34, 95% CI (-1.51, -1.13), P<0.00001], and improved left ventricular ejection fraction (LVEF)[SMD=2.92, 95% CI (2.65, 3.19), P<0.00001], 6-minute walk test (6MWT) [MD=35.59, 95% CI (29.72, 41.47), P<0.00001], and Minnesota Living with Heart Failure Questionnaire (MLHFQ) scores [MD=35.59, 95% CI (29.72, 41.47), P<0.00001] were observed. The incidence of adverse events also decreased [RR=0.25, 95% CI (0.11, 0.56), P=0.0007].CONCLUSIONThe combination of Qi benefiting and blood circulation promoting herbs with Dapagliflozin shows potential in treating patients with T2DM and HF, suggesting its use as adjunctive therapy in clinical practice. However, the limited number and quality of the included studies necessitate further high-quality research to confirm these findings.
方法对益气活血中药联合达帕格列净治疗 2 型糖尿病(T2DM)合并心力衰竭(HF)的随机对照试验(RCT)进行了评估。检索时间跨度为数据库建立至 2023 年 6 月,包括 7 个数据库:中国知网(CNKI)、万方数据库、VIP数据库、PubMed、Embase、Cochrane图书馆和中国生物医学文献数据库。两名研究人员根据纳入和排除标准筛选和提取数据。结果共纳入 7 篇文章,样本量为 1192 例。荟萃分析结果表明,益气活血中药与达帕利洛嗪合用可提高临床有效率[OR=4.35,95% CI (2.98,6.35),P<0.00001]。它降低了血糖水平,表现为空腹血糖(FBG)降低[MD=-1.19,95% CI(-1.30,-1.09),P<0.00001],餐后 2 小时血糖(2hPG)降低[MD=-1.95,95% CI(-2.09,-1.80),P<0.00001]和糖化血红蛋白(HbA1c)[MD=-1.40,95% CI(-1.49,-1.31),P<0.00001]。炎症因子也有所降低,包括C反应蛋白(CRP)[MD=-4.93,95% CI(-5.38,-4.48),P<0.00001]、肿瘤坏死因子(TNF-α)[MD=-2.91,95% CI(-3.32,-2.49),P<0.00001]和白细胞介素-6(IL-6)[MD=-11.10,95% CI(-12.43,-9.43),P<0.00001]。此外,左心室舒张末期直径(LVEDD)[SMD=-1.25,95% CI(-1.45,-1.05),P<0.00001]、左心室收缩末期直径(LVESD)[SMD=-1.34,95% CI(-1.51,-1.13),P<0.00001]和左心室射血分数(LVEF)[SMD=2.92,95% CI (2.65,3.19),P<0.00001]、6分钟步行测试(6MWT)[MD=35.59,95% CI (29.72,41.47),P<0.00001]和明尼苏达心衰患者生活问卷(MLHFQ)评分[MD=35.59,95% CI (29.72,41.47),P<0.00001]均有所改善。结论益气活血中药与达帕利洛嗪联合治疗T2DM合并HF患者显示出潜力,建议在临床实践中作为辅助治疗使用。然而,由于纳入研究的数量和质量有限,有必要进一步开展高质量的研究来证实这些发现。
{"title":"Combination of Qi benefiting and blood circulation promoting herbs with Dapagliflozin in the treatment of type 2 diabetes mellitus combined with heart failure: a systematic evaluation and meta-analysis based on a randomized controlled trial.","authors":"Changxing Liu,Xinyi Guo,He Wang,Yabin Zhou","doi":"10.1159/000541234","DOIUrl":"https://doi.org/10.1159/000541234","url":null,"abstract":"INTRODUCTIONThis systematic review examines the efficacy of a combination of Qi benefiting and blood circulation promoting herbs with Dapagliflozin in treating type 2 diabetes mellitus (T2DM) combined with heart failure (HF).METHODSRandomized controlled trials (RCTs) assessing the combination of Qi benefiting and blood circulation promoting herbs with Dapagliflozin for T2DM and CHF was conducted. The search, spanning from the database's establishment to June 2023, included seven databases: China Knowledge Network (CNKI), Wanfang Database, VIP Database, PubMed, Embase, Cochrane Library, and the Chinese Biomedical Literature Database. Two researchers screened and extracted data based on inclusion and exclusion criteria. The Cochrane Handbook version 5.1 guided the quality assessment of studies, and the meta-analysis was performed using RevMan 5.4 software.RESULTSEleven articles, encompassing a sample size of 1192 cases, were included. Meta-analysis results indicated that combining Qi benefiting and blood circulation promoting herbs with Dapagliflozin improved the clinical efficacy rate [OR=4.35, 95% CI (2.98, 6.35), P<0.00001]. It reduced blood glucose levels, evidenced by decreased fasting blood glucose (FBG) [MD=-1.19, 95% CI (-1.30, -1.09), P<0.00001], 2-hour postprandial blood glucose (2hPG) [MD=-1.95, 95% CI (-2.09, -1.80), P<0.00001], and glycosylated haemoglobin (HbA1c) [MD=-1.40, 95% CI (-1.49, -1.31), P<0.00001]. Inflammatory factors also reduced, including C-reactive protein (CRP) [MD=-4.93, 95% CI (-5.38, -4.48), P<0.00001], tumor necrosis factor (TNF-α) [MD=-2.91, 95% CI (-3.32, -2.49), P<0.00001], and interleukin-6 (IL-6) [MD=-11.10, 95% CI (-12.43, -9.43), P<0.00001]. Additionally, left ventricular end-diastolic diameter (LVEDD) [SMD=-1.25, 95% CI (-1.45, -1.05), P<0.00001], left ventricular end-systolic diameter (LVESD) [SMD=-1.34, 95% CI (-1.51, -1.13), P<0.00001], and improved left ventricular ejection fraction (LVEF)[SMD=2.92, 95% CI (2.65, 3.19), P<0.00001], 6-minute walk test (6MWT) [MD=35.59, 95% CI (29.72, 41.47), P<0.00001], and Minnesota Living with Heart Failure Questionnaire (MLHFQ) scores [MD=35.59, 95% CI (29.72, 41.47), P<0.00001] were observed. The incidence of adverse events also decreased [RR=0.25, 95% CI (0.11, 0.56), P=0.0007].CONCLUSIONThe combination of Qi benefiting and blood circulation promoting herbs with Dapagliflozin shows potential in treating patients with T2DM and HF, suggesting its use as adjunctive therapy in clinical practice. However, the limited number and quality of the included studies necessitate further high-quality research to confirm these findings.","PeriodicalId":10541,"journal":{"name":"Complementary Medicine Research","volume":"64 1","pages":"1-28"},"PeriodicalIF":1.8,"publicationDate":"2024-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142247391","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}